Back

Effect of statins on mortality in patients with COVID-19: an updated meta-analysis of 147824 patients

29 August 2021 (20:42 - 20:51)
Organised by:
Congress Presentation Part of: COVID-19 and cardiovascular pharmacotherapy Lipid-Lowering Agents ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Carlos Diaz-Arocutipa

Universidad San Ignacio de Loyola, Lima (Peru)

4 More presentations in this session

Presentation thumbnail
Effect of prophylactic and therapeutic low molecular weight heparins on mortality in 15,704 COVID-19 patients. A systematic review and a meta-analysis.
Doctor A. Pani (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).
Doctor F. Santoro (Foggia, IT)
Abstract Slides Video
Presentation thumbnail
Early experience utilizing bivalirudin as anticoagulation in extracorporeal membrane oxygen in coronavirus disease 2019
Doctor C. Jones (West Palm Beach, US)
Abstract Slides Video
Presentation thumbnail
Management and impact of atrial fibrillation in the COVID 19 era; concomitancy of two procoagulant phenomena
Doctor A. Arteagoitia Bolumburu (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
COVID-19 and cardiovascular pharmacotherapy

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 20:42 CET
You may be interested in
thumbnail
Congress Presentation
Where are we now? Decision-making in LDL-C lowering and CV risk
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources